Simulated sunlight decreases the viability of SARS-CoV-2 in mucus.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 13 01 2021
accepted: 27 05 2021
entrez: 10 6 2021
pubmed: 11 6 2021
medline: 24 6 2021
Statut: epublish

Résumé

The novel coronavirus, SARS-CoV-2, has spread into a pandemic since its emergence in Wuhan, China in December of 2019. This has been facilitated by its high transmissibility within the human population and its ability to remain viable on inanimate surfaces for an extended period. To address the latter, we examined the effect of simulated sunlight on the viability of SARS-CoV-2 spiked into tissue culture medium or mucus. The study revealed that inactivation took 37 minutes in medium and 107 minutes in mucus. These times-to-inactivation were unexpected since they are longer than have been observed in other studies. From this work, we demonstrate that sunlight represents an effective decontamination method but the speed of decontamination is variable based on the underlying matrix. This information has an important impact on the development of infection prevention and control protocols to reduce the spread of this deadly pathogen.

Identifiants

pubmed: 34111204
doi: 10.1371/journal.pone.0253068
pii: PONE-D-21-01351
pmc: PMC8191973
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0253068

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Rev Sci Tech. 1991 Sep;10(3):733-48
pubmed: 1782426
J Virol Methods. 2003 Sep;112(1-2):3-12
pubmed: 12951207
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
Am J Public Health Nations Health. 1947 May;37(5):529-37
pubmed: 18016521
Photodiagnosis Photodyn Ther. 2020 Dec;32:101995
pubmed: 32916328
mSphere. 2020 Jul 1;5(4):
pubmed: 32611701
Lancet Microbe. 2020 May;1(1):e10
pubmed: 32835322
Am J Respir Crit Care Med. 2015 Aug 15;192(4):477-84
pubmed: 25928547
Virol J. 2020 Oct 7;17(1):145
pubmed: 33028356
Appl Microbiol. 1964 Sep;12:418-20
pubmed: 14215971
J Infect Dis. 2020 Jun 29;222(2):214-222
pubmed: 32432672
Semin Oncol Nurs. 2016 Aug;32(3):241-54
pubmed: 27539279
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
J Infect. 2020 Jun;80(6):e1-e13
pubmed: 32283156
Water Res. 2017 Feb 1;109:207-216
pubmed: 27889622
Am J Infect Control. 2020 Oct;48(10):1273-1275
pubmed: 32763344
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Food Environ Virol. 2014 Dec;6(4):260-8
pubmed: 24952878
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Sci Total Environ. 2021 Jan 10;751:141816
pubmed: 32861186
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
World J Clin Cases. 2020 Apr 26;8(8):1391-1399
pubmed: 32368532

Auteurs

Angela Sloan (A)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Todd Cutts (T)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Bryan D Griffin (BD)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Samantha Kasloff (S)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Zachary Schiffman (Z)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

Mable Chan (M)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Jonathan Audet (J)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Anders Leung (A)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Darwyn Kobasa (D)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

Derek R Stein (DR)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

David Safronetz (D)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

Guillaume Poliquin (G)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Department of Pediatrics and Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH